PROTEASEHEMMUNG

European patent · EP1981519 · In force

Register entry

Publication number
EP1981519
Application number
EP06848187
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 27, 2006
Published
Oct 22, 2008
Granted
Dec 27, 2017
Protection ends at the latest
Dec 26, 2026
Next annual fee due
Dec 31, 2026
IPC classes
C07K 14/81 (2006.01)
A61K 38/00 (2006.01)
Priority
US 754903 P 29.12.2005
PCT application
PCT/US2006/049322 27.12.2006
PCT publication
WO2007/079096 12.07.2007
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. May 29, 2021

    Transferred

    Owner
    Dyax Corp., 55 Network Drive, Burlington, MA 01803, USA → Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan

    Published in Swissreg on 29.05.2021

  6. Dec 27, 2017

    Granted

    Published in Swissreg on 27.12.2017

Parties

Holder

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka, JP

Inventor

LADNER, Robert C.

Ijamsville, Maryland 21754, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.